Clinical Trials Browser

Phase 1 × Completed × TIC10 compound × Clear all

NCT02609230 2021-06-04

A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma

Phase 1 Completed

Multiple Myeloma

NCT02250781 2019-05-22

Oral ONC201 in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT02324621 2019-05-22

Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor